NASDAQ: AFMD       Affimed N.V.
Last Price Today's Change   Day's Range   Trading Volume
3.23   +0.11 (3.53%)  2.97 - 3.38  663,758


Avg Volume (4 weeks):1,423,073
4 Weeks Range:1.88 - 3.39
4 Weeks Price Volatility (%):
52 Weeks Range:1.42 - 3.74
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's own immune defenses to fight tumor cells. It is also developing single and combination therapies to treat cancers and other life-threatening diseases. The company generates its pipeline of product candidates from several proprietary platform technologies NK-cell and T-cell TandAbs, tri specific Abs and alternative antibody formats. The company's operations are located in Germany, Europe, and the USA.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2146  3517  374  2914 

Top 10 Active Counters
 JCP 0.1820.00 
 AVP 5.60-0.05 
 GE 6.52-0.26 
 PHIO 4.089+1.849 
 PRTY 1.425+0.405 
 AABA 19.630.00 
 ADAP 10.20+5.34 
 TGE 22.39+0.81 
 SQQQ 9.752-0.078 
 F 5.685-0.165 
Partners & Brokers